Long-Term Safety, Tolerability and Efficacy in Perampanel Treated Parkinson's Disease Patients With Motor Fluctuations

NCT01634360 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

185

Enrollment

INDUSTRY

Sponsor class

Stopped Due to termination of clinical program for Parkinson's Disease

Conditions

Parkinson's Disease

Interventions

DRUG: Perampanel

Sponsor

Eisai Inc.